PRE 14A XBRL

PRELIMINARY PROXY STATEMENT

Company: Silo Pharma, Inc.
Filed: August 25, 2025
Period of Report: August 25, 2025
Accession Number: 0002077096-25-000053

View Document ↗ View on SEC.gov ↗